Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
Hematological Oncology|October 1, 2021
A perspective on prognostic models in chronic lymphocytic leukemia in the era of targeted agentsStefano Molica, John F Seymour, Aaron Polliack
Leukemia & Lymphoma|April 10, 2008
Early interim PET scan in Hodgkin lymphoma: where do we stand?Andrea Gallamini, Martin Hutchings, Abraham Avigdor, et al.
Anticancer Research|August 1, 2018
The Frequency and Prognostic Value of Neutrophilia in Chronic Lymphocytic LeukemiaIlana Levy, Zahava Vadasz, Aaron Polliack, et al.
Hematological Oncology|November 17, 2019
Ibrutinib in the treatment of chronic lymphocytic leukemia: 5 years onStefano Molica, Estella Matutes, Constantine Tam, et al.
Hematological Oncology|February 4, 2017
Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphomaNatalia Kreiniz, Jacob Bejar, Aaron Polliack, et al.
Leukemia & Lymphoma|November 17, 2010
Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8-9 April 2010Michel Meignan, Andrea Gallamini, Corinne Haioun, et al.
European Journal of Haematology|May 16, 2006
Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophiliaYair Herishanu, Ori Rogowski, Aaron Polliack, et al.
Hematological Oncology|May 31, 2016
Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-upTamar Tadmor, Irena Liphshitz, Barbara Silverman, et al.
Hematological Oncology|November 8, 2023
Targeting TP53 disruption in chronic lymphocytic leukemia: Current strategies and future directionsStefano Molica, Constantine Tam, David Allsup, et al.
Leukemia & Lymphoma|October 31, 2014
Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapyKrzysztof Jamroziak, Tamar Tadmor, Tadeusz Robak, et al.
Pageof 12